
With its Q3 2025 results on Tuesday, Aurinia Pharmaceuticals (AUPH) said that it recently responded to an information request from the U.S. FDA regarding its lead drug, Lupkynis, which has led to a leadership shake-up at the agency with the exit of
2 hours ago
1

With its Q3 2025 results on Tuesday, Aurinia Pharmaceuticals (AUPH) said that it recently responded to an information request from the U.S. FDA regarding its lead drug, Lupkynis, which has led to a leadership shake-up at the agency with the exit of
© FBT Company 2025. All rights are reserved
